低温プラズマの世界市場予測（2022年～2027年）

世界の低温プラズマの市場規模は、予測期間中に17.13％のCAGRで成長し、2020年の15億9,370万8,000米ドルから、2027年には48億1,983万3,000米ドルに達すると予想されます。

近年、低温プラズマ技術は材料加工業界において幅広く応用され、半導体や特殊ガラスの製造、さらには磁気媒体や金属コーティングにも利用されるようになっています。繊維製造技術の革新と研究開発への投資の増大が、予測期間中の市場成長を促進するものと思われます。しかし、高い設備投資が今後数年間、市場の成長機会を抑制すると予想されます。

当レポートでは、世界の低温プラズマ市場について調査分析し、市場概要、促進要因や抑制要因、レジーム別・業界別・地域別の市場分析、競合情報や企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

• 市場概要
• COVID-19シナリオ
• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • 売り手の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 業界での競合関係
• 業界のバリューチェーン分析

第5章 低温プラズマ市場：レジーム別

• 低圧低温プラズマ
• 大気圧低温プラズマ

第6章 低温プラズマ市場：業界別

• イントロダクション
• 繊維業界
  • 仕上げ
  • 殺菌
  • その他
• 医療業界
  • 創傷治癒
  • 癌治療
  • その他
• ポリマー・プラスチック業界
  • 表面処理
  • その他
• 電子・半導体業界
• その他

第7章 低温プラズマ市場：地域別

• イントロダクション
• 北米
  • 北米の低温プラズマ市場：レジーム別（2020年～2027年）
  • 北米の低温プラズマ市場：業界別（2020年～2027年）
  • 国別
• 南米
  • 南米の低温プラズマ市場：レジーム別（2020年～2027年）
  • 南米の低温プラズマ市場：業界別（2020年～2027年）
  • 国別
• 欧州
  • 欧州の低温プラズマ市場：レジーム別（2020年～2027年）
  • 欧州の低温プラズマ市場：業界別（2020年～2027年）
  • 国別
• 中東・アフリカ
  • 中東・アフリカの低温プラズマ市場：レジーム別（2020年～2027年）
  • 中東・アフリカの低温プラズマ市場：業界別（2020年～2027年）
  • 国別
• アジア太平洋地域
  • アジア太平洋地域の低温プラズマ市場：レジーム別（2020年～2027年）
  • アジア太平洋地域の低温プラズマ市場：業界別（2020年～2027年）
  • 国別

第8章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の収益性
• 合併、買収、契約、およびコラボレーション
• ベンダーの競争力マトリックス

第9章 企業プロファイル

• Nordson Corporation
• Nova Plasma
• Campden BRI Ltd.
• Plasmatreat GmbH
• Apyx Medical Corporation
• Relyon Plasma GmbH
• Adtec Plasma Technology Co., Ltd
• PlasmaDerm
• Thierry Corporation

The global cold plasma market is expected to grow at a CAGR of 17.13% over the forecast period to reach a total market size of US$4819.833 million by 2027, increasing from US$1593.708 million in 2020.

In recent years, cold plasma technology has found extensive application in the material processing industry and is now widely used in the manufacturing of semiconductors, special glasses, and even for magnetic media and metal coating. Innovations in textile production techniques coupled with the growing investment in research and development are expected to drive the growth of the market during the forecast period. However, high capital investment is anticipated to restrain the market's growth opportunities in the coming years.

The textile industry holds a significant share in the market

The textile industry today is moving towards innovative production techniques to improve product quality and meet environmental and social objectives. Plasma treatment has certain advantages as it can modify the surface properties of materials with an environmentally-friendly device. For the treatment of fabrics, cold plasma is used mostly where the ambient treatment atmosphere is near the room temperature. Plasma is a partially ionized gas, composed of highly excited atomic, molecular, ionic, and radical species with free electrons and photons. Some of the most common plasma techniques that are used to treat the textile substrates are Glow Discharge, Atmospheric Pressure Plasma, and Dielectric-Barrier Discharge (DBD), among others. In addition, expanding the textile industry in developing countries like India and China, coupled with favorable government initiatives, is expected to drive the growth of the market over the forecast period. For instance, recently, the Clothing Manufacturers Association of India (CMAI) signed a memorandum of understanding with the China Chamber of Commerce for Import and Export of Textiles (CCCT) to explore the area of operation for increasing exports from India.

Application in healthcare

Recently, the ability of cold atmospheric plasma to inactivate bacteria has gained more relevance as modern society is facing many serious healthcare challenges. One chronic wound like a diabetic ulcer does not heal easily, and one of the problems is the high level of infection caused by a spectrum of bacteria. The inability of conventional forms to solve these problems leads to the growing demand for new approaches and technologies such as cold atmospheric plasma, which has been shown to effectively inactivate bacteria and greatly reduce the burden in infected chronic wounds, making it an attractive technology to overcome such challenges. Furthermore, the use of cold plasma allows effective medical treatment of chronic diseases such as cancer and various skin injuries and diseases, like wounds, bacterial infections, and fungoid infections, among others. Besides, the increasing application, of cold plasma in cancer treatment, wound healing, and infective diseases are augmenting the growth of the market in the coming years.

Geographically North America is holding a significant share of the market

By geography, the cold plasma market is segmented as North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. North America and Europe are projected to show significant market share due to the early adopters of technology and innovations, thus contributing to generating high revenues. On the other hand, the Asia Pacific region is estimated to show high growth prospects with growth in the electronics and semiconductor industry. In addition, due to rising household expenditure, there is an increasing demand for consumer goods which attracts market players to invest in the country to cater to the growing consumer base which is further expected to propel the market growth opportunities for manufacturers and vendors in the coming years. Also, the region is the home of countries like China and Japan, where China is considered one of the biggest manufacturing hubs in the world, and Japan which is one of the most advanced economies in the world and is the world's third-biggest pharmaceuticals market. The growing geriatric population coupled with the increasing investment in the pharmaceutical industry is expected to propel the market growth opportunities for manufacturers and vendors over the forecast period.

Competitive Insights

Prominent key market players in the cold plasma market include Nordson Corporation, Surfx Technologies, LLC, Tantec A/S, Plasmatreat GmbH, AcXys Plasma Technologies, Apyx Medical Corporation, Relyon Plasma GmbH, Adtec Plasma Technology Co., Ltd, Europlasma Nv, and Thierry Corporation. The number of players in the cold plasma market is large and growing with the opportunity to generate significant revenues as a result of growing demand. Key players in the market are seen to adopt differentiated strategies and are either looking to expand their market portfolio with investments in the development of the new product line and product innovation, or some companies are opting for mergers, acquisitions, and strategic partnerships to expand their market presence and/or expand their product line. For instance, in March 2019, the Nordson Company, a global leader in plasma processing technology, will introduce its automated plasma treatment system FlexTRAK@-SHS. The system includes a 9.6-liter large volume F3-S process chamber that can even configure large strips and treat more strips per cycle. Major market players in the global cold plasma market have been covered along with their relative competitive positions and strategies. The report also covers recent deals and investments by major market players over the last couple of years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered, along with the recent deals and investments of these important players in the global cold plasma market.

Key Developments in the market:

• October 2021: Plasmacure, developer of PLASOMA cold plasma systems for treating chronic wounds, entered into a new phase WITH EUROPEAN INVESTMENTS. Through this investment, Plasmacure was able to conduct clinical studies and sell the product globally thanks to a new round of funding from a consortium that includes NextGen Ventures, Topfonds Gelderland, the EIC (European Innovation Council) Fund, and Credenti BV
• November 2021: The NOVOPLASM consortium declared to be the "first in the world" to develop cold plasma technology for the treatment of infected burns and skin graft wound healing. The consortium, which includes CTIBIOTECH, Ecole Polytechnique, the French Armed Forces Biomedical Research Institute, and Institute Pasteur, is using an immunized human skin model produced by 3D bioprinting to aid in the development of the cold plasma treatment.
• May 2022: Apyx Medical Corporation, developer of medical devices and Helium Plasma Technology maker, announced the approval of 510(k) clearance from the FDA for the usage of the Renuvion Dermal Handpiece for specialized dermal resurfacing treatments

COVID-19 Insights:

COVID-19 had a negative impact on the cold plasma market. The rapid spread of the virus across the globe prompted several countries to enforce lockdown nationwide and social distancing measures. Consequently, multiple production facilities were forced to close down, slowing the productivity of the companies. Furthermore, factors like travel restrictions, ports closure, and airline halts sharply reduced the imports and exports across the countries, disrupting the global supply chain.

Segmentation:

• By Industry

Textile Industry

• Finishing
• Sterilization
• Others

Medical Industry

• Wound Healing
• Cancer Treatment
• Others

Polymer & Plastic Industry

• Surface Treatment
• Others

Electronics & Semiconductors Industry

Others

• By Regime

Low-Pressure Cold Plasma

Atmospheric Cold Plasma

• By Geography

North America

• USA
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• UK
• Germany
• France
• Spain
• Italy
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Others

Asia Pacific

• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Covid-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Cold Plasma Market, By Regime

• 5.1. Low-Pressure Cold Plasma
• 5.2. Atmospheric Cold Plasma

6. Cold Plasma Market, By Industry

• 6.1. Introduction
• 6.2. Textile Industry
  • 6.2.1. Finishing
  • 6.2.2. Sterilization
  • 6.2.3. Others
• 6.3. Medical Industry
  • 6.3.1. Wound Healing
  • 6.3.2. Cancer Treatment
  • 6.3.3. Others
• 6.4. Polymer & Plastic Industry
  • 6.4.1. Surface Treatment
  • 6.4.2. Others
• 6.5. Electronics & Semiconductors Industry
• 6.6. Others

7. Cold Plasma Market, By Geography 

• 7.1. Introduction
• 7.2. North America 
  • 7.2.1. North America Cold Plasma Market, By Regime, 2020 To 2027
  • 7.2.2. North America Cold Plasma Market, By Industry, 2020 To 2027
  • 7.2.3. By Country
    • 7.2.3.1. United States
    • 7.2.3.2. Canada
    • 7.2.3.3. Mexico 
• 7.3. South America
  • 7.3.1. South America Cold Plasma Market, By Regime, 2020 To 2027
  • 7.3.2. South America Cold Plasma Market, By Industry, 2020 To 2027
  • 7.3.3. By Country
    • 7.3.3.1. Brazil 
    • 7.3.3.2. Argentina
    • 7.3.3.3. Others
• 7.4. Europe 
  • 7.4.1. Europe Cold Plasma Market, By Regime, 2020 To 2027
  • 7.4.2. Europe Cold Plasma Market, By Industry, 2020 To 2027
  • 7.4.3. By Country
    • 7.4.3.1. UK 
    • 7.4.3.2. Germany 
    • 7.4.3.3. France
    • 7.4.3.4. Spain
    • 7.4.3.5. Italy 
    • 7.4.3.6. Others
• 7.5. Middle East and Africa 
  • 7.5.1. Middle East and Africa Cold Plasma Market, By Regime, 2020 To 2027
  • 7.5.2. Middle East and Africa Cold Plasma Market, By Industry, 2020 To 2027
  • 7.5.3. By Country
    • 7.5.3.1. Saudi Arabia
    • 7.5.3.2. UAE 
    • 7.5.3.3. Others
• 7.6. Asia Pacific 
  • 7.6.1. Asia Pacific Cold Plasma Market, By Regime, 2020 To 2027
  • 7.6.2. Asia Pacific Cold Plasma Market, By Industry, 2020 To 2027
  • 7.6.3. By Country
    • 7.6.3.1. Japan
    • 7.6.3.2. China 
    • 7.6.3.3. India 
    • 7.6.3.4. South Korea 
    • 7.6.3.5. Indonesia
    • 7.6.3.6. Thailand
    • 7.6.3.7. Taiwan
    • 7.6.3.8. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. Nordson Corporation
• 9.2. Nova Plasma
• 9.3. Campden BRI Ltd.
• 9.4. Plasmatreat GmbH
• 9.5. Apyx Medical Corporation
• 9.6. Relyon Plasma GmbH 
• 9.7. Adtec Plasma Technology Co., Ltd
• 9.8. PlasmaDerm
• 9.9. Thierry Corporation